QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development.
Its AI solution enables ClinDev and ClinOps teams to holistically simulate a clinical trial in thousands of variations within minutes, allowing users to evaluate each parameter on endpoint success, commercial viability, and protocol feasibility. Its In-Silico platform generates synthetic evidence for how therapy will perform across all clinical phases, as soon as its mechanism is known, and preclinical evidence has been established. The synthetic evidence generation engine can be used to support trial planning, as well as indication selection, drug repurposing and in-licensing asset evaluation.
The company Large Healthcare Model (LHM) learns deep patient-drug interactions that drive high-resolution outcome models with 86% endpoint accuracy. Its models continually adapt as new research comes forward, and can be further enhanced with internal trial data and proprietary research.